trichorfon(ISO，BSI)

物化性质

外观与性状：

纯品为白色结晶，有醛类气味。

密度：

1.73

熔点：

77-81 °C

沸点：

100°C

闪点：

116.7°C

水溶解性：

略溶于水. 1-5 G/100 ML AT 21 ºC

折射率：

1.3439

存储条件/存储方法：

2-8°C

稳定性相关：

1.易水解和脱氯化氢反应，加热，>pH6时分解迅速，光解缓慢。被碱很快地转化成敌敌畏，22℃ 水解时，半衰期随pH值增 加而缩短。

2.稳定性^[17] 稳定

3.禁配物^[18] 强氧化剂、强碱

4.避免接触的条件^[19] 受热

5.聚合危害^[20] 不聚合

6.分解产物^[21] 氯化氢、氧化磷

其它信息：

1.性状：纯品为白色结晶，有醛类气味。^[1]

2.熔点（℃）：83~84^[2]

3.沸点（℃）：100（13.3Pa）^[3]

4.相对密度（水=1）：1.73^[4]

5.饱和蒸气压（kPa）：13.33（100℃）^[5]

6.辛醇/水分配系数：0.51^[6]

7.溶解性：溶于水、氯仿，不溶于汽油。^[7]

安全信息

外观与性状：

纯品为白色结晶，有醛类气味。

密度：

1.73

熔点：

77-81 °C

沸点：

100°C

闪点：

116.7°C

水溶解性：

略溶于水. 1-5 G/100 ML AT 21 ºC

折射率：

1.3439

存储条件/存储方法：

2-8°C

稳定性相关：

1.易水解和脱氯化氢反应，加热，>pH6时分解迅速，光解缓慢。被碱很快地转化成敌敌畏，22℃ 水解时，半衰期随pH值增 加而缩短。

2.稳定性^[17] 稳定

3.禁配物^[18] 强氧化剂、强碱

4.避免接触的条件^[19] 受热

5.聚合危害^[20] 不聚合

6.分解产物^[21] 氯化氢、氧化磷

其它信息：

1.性状：纯品为白色结晶，有醛类气味。^[1]

2.熔点（℃）：83~84^[2]

3.沸点（℃）：100（13.3Pa）^[3]

4.相对密度（水=1）：1.73^[4]

5.饱和蒸气压（kPa）：13.33（100℃）^[5]

6.辛醇/水分配系数：0.51^[6]

7.溶解性：溶于水、氯仿，不溶于汽油。^[7]

毒理性

CHEMICAL IDENTIFICATION

RTECS NUMBER :

TA0700000

CHEMICAL NAME :

Phosphonic acid, (2,2,2-trichloro-1-hydroxyethyl)-, dimethyl ester

CAS REGISTRY NUMBER :

52-68-6

BEILSTEIN REFERENCE NO. :

1709434

LAST UPDATED :

199712

DATA ITEMS CITED :

117

MOLECULAR FORMULA :

C4-H8-Cl3-O4-P

MOLECULAR WEIGHT :

257.44

WISWESSER LINE NOTATION :

GXGGYQPO&O1&O1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :

Standard Draize test

ROUTE OF EXPOSURE :

Administration into the eye

SPECIES OBSERVED :

Rodent - rabbit

TYPE OF TEST :

TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :

Inhalation

SPECIES OBSERVED :

Human

DOSE/DURATION :

1710 ug/m3/90D-I

TOXIC EFFECTS :

Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Oral

SPECIES OBSERVED :

Rodent - rat

DOSE/DURATION :

560 mg/kg

TOXIC EFFECTS :

Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :

LC50 - Lethal concentration, 50 percent kill

ROUTE OF EXPOSURE :

Inhalation

SPECIES OBSERVED :

Rodent - rat

DOSE/DURATION :

1300 mg/m3

TOXIC EFFECTS :

Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Administration onto the skin

SPECIES OBSERVED :

Rodent - rat

DOSE/DURATION :

2 gm/kg

TOXIC EFFECTS :

Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Intraperitoneal

SPECIES OBSERVED :

Rodent - rat

DOSE/DURATION :

160 mg/kg

TOXIC EFFECTS :

Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Subcutaneous

SPECIES OBSERVED :

Rodent - rat

DOSE/DURATION :

400 mg/kg

TOXIC EFFECTS :

Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Intramuscular

SPECIES OBSERVED :

Rodent - rat

DOSE/DURATION :

395 mg/kg

TOXIC EFFECTS :

Cardiac - other changes Liver - other changes Blood - hemorrhage

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Unreported

SPECIES OBSERVED :

Rodent - rat

DOSE/DURATION :

550 mg/kg

TOXIC EFFECTS :

Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Oral

SPECIES OBSERVED :

Rodent - mouse

DOSE/DURATION :

300 mg/kg

TOXIC EFFECTS :

Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Administration onto the skin

SPECIES OBSERVED :

Rodent - mouse

DOSE/DURATION :

1710 mg/kg

TOXIC EFFECTS :

Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Intraperitoneal

SPECIES OBSERVED :

Rodent - mouse

DOSE/DURATION :

196 mg/kg

TOXIC EFFECTS :

Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Subcutaneous

SPECIES OBSERVED :

Rodent - mouse

DOSE/DURATION :

267 mg/kg

TOXIC EFFECTS :

Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Intravenous

SPECIES OBSERVED :

Rodent - mouse

DOSE/DURATION :

290 mg/kg

TOXIC EFFECTS :

Cardiac - other changes Liver - other changes Blood - hemorrhage

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Unreported

SPECIES OBSERVED :

Rodent - mouse

DOSE/DURATION :

445 mg/kg

TOXIC EFFECTS :

Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Oral

SPECIES OBSERVED :

Mammal - dog

DOSE/DURATION :

400 mg/kg

TOXIC EFFECTS :

Cardiac - other changes Liver - other changes Blood - hemorrhage

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Subcutaneous

SPECIES OBSERVED :

Mammal - dog

DOSE/DURATION :

269 mg/kg

TOXIC EFFECTS :

Behavioral - tremor Gastrointestinal - changes in structure or function of salivary glands Gastrointestinal - other changes

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Intravenous

SPECIES OBSERVED :

Mammal - dog

DOSE/DURATION :

150 mg/kg

TOXIC EFFECTS :

Cardiac - other changes Liver - other changes Blood - hemorrhage

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Oral

SPECIES OBSERVED :

Mammal - cat

DOSE/DURATION :

97 mg/kg

TOXIC EFFECTS :

Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Unreported

SPECIES OBSERVED :

Mammal - cat

DOSE/DURATION :

98 mg/kg

TOXIC EFFECTS :

Lungs, Thorax, or Respiration - structural or functional change in trachea or bronchi Lungs, Thorax, or Respiration - bronchiolar constriction Lungs, Thorax, or Respiration - acute pulmonary edema

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Oral

SPECIES OBSERVED :

Rodent - rabbit

DOSE/DURATION :

160 mg/kg

TOXIC EFFECTS :

Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :

LD - Lethal dose

ROUTE OF EXPOSURE :

Administration onto the skin

SPECIES OBSERVED :

Rodent - rabbit

DOSE/DURATION :

>1500 mg/kg

TOXIC EFFECTS :

Skin and Appendages - dermatitis, irritative (after systemic exposure) Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Intraperitoneal

SPECIES OBSERVED :

Rodent - rabbit

DOSE/DURATION :

60 mg/kg

TOXIC EFFECTS :

Sense Organs and Special Senses (Eye) - lacrimation Behavioral - convulsions or effect on seizure threshold Gastrointestinal - changes in structure or function of salivary glands

TYPE OF TEST :

LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :

Intramuscular

SPECIES OBSERVED :

Rodent - rabbit

DOSE/DURATION :

500 mg/kg

TOXIC EFFECTS :

Vascular - other changes Lungs, Thorax, or Respiration - other changes Blood - hemorrhage

TYPE OF TEST :

LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :

Oral

SPECIES OBSERVED :

Rodent - guinea pig

DOSE/DURATION :

420 mg/kg

TOXIC EFFECTS :

Lungs, Thorax, or Respiration - other changes Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Intraperitoneal

SPECIES OBSERVED :

Rodent - guinea pig

DOSE/DURATION :

300 mg/kg

TOXIC EFFECTS :

Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Intraperitoneal

SPECIES OBSERVED :

Rodent - hamster

DOSE/DURATION :

1 gm/kg

TOXIC EFFECTS :

Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Oral

SPECIES OBSERVED :

Bird - chicken

DOSE/DURATION :

75 mg/kg

TOXIC EFFECTS :

Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Subcutaneous

SPECIES OBSERVED :

Bird - chicken

DOSE/DURATION :

125 mg/kg

TOXIC EFFECTS :

Peripheral Nerve and Sensation - flaccid paralysis without anesthesia (usually neuromuscular blockage)

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Oral

SPECIES OBSERVED :

Bird - quail

DOSE/DURATION :

73110 ug/kg

TOXIC EFFECTS :

Behavioral - tremor Behavioral - convulsions or effect on seizure threshold Gastrointestinal - hypermotility, diarrhea

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Administration onto the skin

SPECIES OBSERVED :

Mammal - species unspecified

DOSE/DURATION :

>2800 mg/kg

TOXIC EFFECTS :

Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Unreported

SPECIES OBSERVED :

Mammal - species unspecified

DOSE/DURATION :

295 mg/kg

TOXIC EFFECTS :

Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Oral

SPECIES OBSERVED :

Bird - wild bird species

DOSE/DURATION :

37 mg/kg

TOXIC EFFECTS :

Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

SPECIES OBSERVED :

Rodent - rat

DOSE/DURATION :

672 mg/kg/90D-C

TOXIC EFFECTS :

Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

SPECIES OBSERVED :

Rodent - rat

DOSE/DURATION :

780 mg/kg/10D-I

TOXIC EFFECTS :

Biochemical - Neurotransmitters or modulators (putative) - catecholamine levels in CNS Biochemical - Neurotransmitters or modulators (putative) - dopamine at other sites

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

SPECIES OBSERVED :

Rodent - rat

DOSE/DURATION :

562 mg/kg/30D-I

TOXIC EFFECTS :

Brain and Coverings - other degenerative changes Liver - other changes Kidney, Ureter, Bladder - other changes

TYPE OF TEST :

TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :

Inhalation

SPECIES OBSERVED :

Rodent - rat

DOSE/DURATION :

59 mg/m3/14H/80D-I

TOXIC EFFECTS :

Vascular - regional or general arteriolar or venous dilation Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - phosphatases Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - dehydrogenases

TYPE OF TEST :

TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :

Inhalation

SPECIES OBSERVED :

Rodent - rat

DOSE/DURATION :

2 mg/m3/4H/17W-I

TOXIC EFFECTS :

Kidney, Ureter, Bladder - other changes Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Intraperitoneal

SPECIES OBSERVED :

Rodent - rat

DOSE/DURATION :

3 gm/kg/15D-I

TOXIC EFFECTS :

Peripheral Nerve and Sensation - recording from peripheral motor nerve

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Intraperitoneal

SPECIES OBSERVED :

Rodent - rat

DOSE/DURATION :

6 gm/kg/60D-I

TOXIC EFFECTS :

Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - other changes Related to Chronic Data - death

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

SPECIES OBSERVED :

Rodent - mouse

DOSE/DURATION :

2100 mg/kg/14D-C

TOXIC EFFECTS :

Liver - changes in liver weight Blood - other changes Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

SPECIES OBSERVED :

Mammal - dog

DOSE/DURATION :

1050 mg/kg/12W-C

TOXIC EFFECTS :

Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Subcutaneous

SPECIES OBSERVED :

Bird - chicken

DOSE/DURATION :

300 mg/kg/5D-I

TOXIC EFFECTS :

Brain and Coverings - demyelination Behavioral - ataxia Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - other esterases

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

SPECIES OBSERVED :

Rodent - rat

DOSE/DURATION :

186 mg/kg/6W-I

TOXIC EFFECTS :

Tumorigenic - Carcinogenic by RTECS criteria Liver - tumors Blood - tumors

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Administration onto the skin

SPECIES OBSERVED :

Rodent - rat

DOSE/DURATION :

1950 mg/kg/22W-I

TOXIC EFFECTS :

Tumorigenic - equivocal tumorigenic agent by RTECS criteria Liver - tumors

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Intramuscular

SPECIES OBSERVED :

Rodent - rat

DOSE/DURATION :

183 mg/kg/6W-I

TOXIC EFFECTS :

Tumorigenic - Carcinogenic by RTECS criteria Liver - tumors Blood - tumors

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

DOSE :

78400 ug/kg

SEX/DURATION :

female 16-22 day(s) after conception

TOXIC EFFECTS :

Reproductive - Effects on Newborn - biochemical and metabolic

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

DOSE :

80 mg/kg

SEX/DURATION :

female 13 day(s) after conception

TOXIC EFFECTS :

Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea) Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth)

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

DOSE :

80 mg/kg

SEX/DURATION :

female 9 day(s) after conception

TOXIC EFFECTS :

Reproductive - Effects on Embryo or Fetus - fetal death Reproductive - Specific Developmental Abnormalities - homeostasis

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

DOSE :

1450 mg/kg

SEX/DURATION :

female 6-15 day(s) after conception

TOXIC EFFECTS :

Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue) Reproductive - Specific Developmental Abnormalities - musculoskeletal system

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

DOSE :

750 mg/kg

SEX/DURATION :

female 6-15 day(s) after conception

TOXIC EFFECTS :

Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

DOSE :

2200 ug/kg

SEX/DURATION :

female 1-22 day(s) after conception

TOXIC EFFECTS :

Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

DOSE :

12210 mg/kg

SEX/DURATION :

male 60 day(s) pre-mating female 14 day(s) pre-mating

TOXIC EFFECTS :

Reproductive - Maternal Effects - other effects Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea) Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth)

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

DOSE :

1500 mg/kg

SEX/DURATION :

female 10-14 day(s) after conception

TOXIC EFFECTS :

Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

DOSE :

1800 mg/kg

SEX/DURATION :

female 12-14 day(s) after conception

TOXIC EFFECTS :

Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

DOSE :

3 gm/kg

SEX/DURATION :

female 7-16 day(s) after conception

TOXIC EFFECTS :

Reproductive - Specific Developmental Abnormalities - urogenital system

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

DOSE :

4 gm/kg

SEX/DURATION :

female 7-16 day(s) after conception

TOXIC EFFECTS :

Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Effects on Embryo or Fetus - fetal death

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Intraperitoneal

DOSE :

60 mg/kg

SEX/DURATION :

female 9 day(s) after conception

TOXIC EFFECTS :

Reproductive - Effects on Embryo or Fetus - fetal death

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Intraperitoneal

DOSE :

206 mg/kg

SEX/DURATION :

female 2-5 day(s) after conception

TOXIC EFFECTS :

Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Unreported

DOSE :

4200 mg/kg

SEX/DURATION :

female 1-21 day(s) after conception

TOXIC EFFECTS :

Reproductive - Specific Developmental Abnormalities - musculoskeletal system

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

DOSE :

700 mg/kg

SEX/DURATION :

female 2-15 day(s) after conception

TOXIC EFFECTS :

Reproductive - Fertility - other measures of fertility Reproductive - Effects on Embryo or Fetus - maternal-fetal exchange

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

DOSE :

600 mg/kg

SEX/DURATION :

female 36-53 day(s) after conception

TOXIC EFFECTS :

Reproductive - Fertility - abortion Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Specific Developmental Abnormalities - Central Nervous System

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

DOSE :

600 mg/kg

SEX/DURATION :

female 36-53 day(s) after conception

TOXIC EFFECTS :

Reproductive - Specific Developmental Abnormalities - musculoskeletal system Reproductive - Effects on Newborn - stillbirth Reproductive - Effects on Newborn - other neonatal measures or effects

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Unreported

DOSE :

375 mg/kg

SEX/DURATION :

female 42-44 day(s) after conception

TOXIC EFFECTS :

Reproductive - Specific Developmental Abnormalities - Central Nervous System

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

DOSE :

2 gm/kg

SEX/DURATION :

female 7-11 day(s) after conception

TOXIC EFFECTS :

Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue) Reproductive - Specific Developmental Abnormalities - musculoskeletal system Reproductive - Specific Developmental Abnormalities - homeostasis

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

DOSE :

2 gm/kg

SEX/DURATION :

female 7-11 day(s) after conception

TOXIC EFFECTS :

Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth)

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

DOSE :

1500 mg/kg

SEX/DURATION :

female 7-11 day(s) after conception

TOXIC EFFECTS :

Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

DOSE :

400 mg/kg

SEX/DURATION :

female 8 day(s) after conception

TOXIC EFFECTS :

Reproductive - Effects on Embryo or Fetus - fetal death

TYPE OF TEST :

Cytogenetic analysis

TYPE OF TEST :

Cytogenetic analysis

TYPE OF TEST :

DNA damage

TYPE OF TEST :

Cytogenetic analysis

TYPE OF TEST :

Cytogenetic analysis

TYPE OF TEST :

Sister chromatid exchange

TYPE OF TEST :

Dominant lethal test

MUTATION DATA

TYPE OF TEST :

Sister chromatid exchange

TEST SYSTEM :

Rodent - hamster Ovary

DOSE/DURATION :

2 gm/L

REFERENCE :

NTIS** National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific & Technical Information. Volume(issue)/page/year: PB84-138973 *** REVIEWS *** IARC Cancer Review:Animal Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 30,207,1983 IARC Cancer Review:Human No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 30,207,1983 IARC Cancer Review:Group 3 IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,56,1987 TOXICOLOGY REVIEW CRTXB2 CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton, FL 33431) V.1- 1971- Volume(issue)/page/year: 3,289,1975 TOXICOLOGY REVIEW RREVAH Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1962- Volume(issue)/page/year: 46,1,1973 TOXICOLOGY REVIEW MZUZA8 Meditsinskii Zhurnal Uzbekistana. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) No.1- 1957- Volume(issue)/page/year: (8),90,1973 TOXICOLOGY REVIEW CNDQA8 Cahiers de Nutrition et de Dietetique. (Editions Meteore, 42, rue du Louvre, 75001 Paris, France) V.1- 1966- Volume(issue)/page/year: 10(3),43,1975 TOXICOLOGY REVIEW DTTIAF Deutsche Tieraerztliche Wochenschrift. (Hanover, Fed. Rep. Ger.) V.1-77, 1893-1970. Volume(issue)/page/year: 80,485,1973 TOXICOLOGY REVIEW RREVAH Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1962- Volume(issue)/page/year: 63,1,1976 *** U.S. STANDARDS AND REGULATIONS *** EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION FEREAC Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- Volume(issue)/page/year: 54,7740,1989 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-RUSSIA:STEL 0.5 mg/m3;Skin JAN 1993 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA ***NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - T0248 No. of Facilities: 473 (estimated) No. of Industries: 1 No. of Occupations: 1 No. of Employees: 9450 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - T0248 No. of Facilities: 19 (estimated) No. of Industries: 1 No. of Occupations: 1 No. of Employees: 338 (estimated) No. of Female Employees: 131 (estimated)

毒理学数据：

1.急性毒性^[8]

LD50：400~900mg/kg（大鼠经口）；500mg/kg（兔经皮）

2.刺激性^[9] 家兔经眼：120mg（6d，间歇），轻度刺激。

3.致突变性^[10] 微生物致突变性：鼠伤寒沙门菌3400nmol/皿。哺乳动物体细胞突变性：小鼠淋巴细胞80mg/L。姐妹染色单体交换：仓鼠肺20mg/L。程序外DNA合成：人成纤维细胞100mg/L。细胞遗传学分析：人白细胞40mg/L。

4.致畸性^[11] 大鼠孕后6~15d经口给予最低中毒剂量（TDLo）1450mg/kg，致中枢神经系统、颅面部（包括鼻、舌）和肌肉骨骼系统发育畸形。小鼠孕后7~16d经口给予最低中毒剂量（TDLo）3g/kg，致泌尿生殖系统发育畸形。

5.致癌性^[12] IARC致癌性评论：G3，对人及动物致癌性证据不足。

6.其他^[13] 大鼠经口最低中毒剂量（TDLo）：1450mg/kg（孕6~15d），致中枢神经系统发育、颅面发育、肌肉骨骼发育异常。

生态数据：

1.生态毒性^[14]

LC50：1.4mg/L（96h）（虹鳟鱼）；0.94mg/L（96h）（蓝鳃太阳鱼）

EC50：0.00018mg/L（48h）（水蚤）

2.生物降解性^[15]

好氧生物降解（h）：24~1080

厌氧生物降解（h）：96~4320

3.非生物降解性^[16]

光解最大光吸收（nm）：＜200

空气中光氧化半衰期（h）：1~101

一级水解半衰期（h）：68

MSDS

模块1. 化学品
1.1 产品标识符
: 敌百虫
产品名称
1.2 鉴别的其他方法
无数据资料
1.3 有关的确定了的物质或混合物的用途和建议不适合的用途
仅用于研发。不作为药品、家庭或其它用途。
模块2. 危险性概述
2.1 GHS分类
急性毒性, 经口 (类别 4)
急性毒性, 经皮 (类别 4)
呼吸过敏 (类别 1)
急性水生毒性 (类别 1)
慢性水生毒性 (类别 1)
2.2 GHS 标记要素，包括预防性的陈述
象形图
警示词危险
危险申明
H302 + H312吞咽或皮肤接触有害。
H334吸入可能导致过敏或哮喘病症状或呼吸困难。
H410对水生生物毒性极大并具有长期持续影响。
警告申明
预防措施
P261避免吸入粉尘/烟/气体/烟雾/蒸气/喷雾。
P264操作后彻底清洗皮肤。
P270使用本产品时不要进食、饮水或吸烟。
P273避免释放到环境中。
P280戴防护手套/穿防护服。
P284[在通风不足的情况下]戴呼吸防护装置。
事故响应
P301 + P312 + P330如果吞咽并觉不适: 立即呼叫解毒中心或就医。漱口。
P302 + P352 + P312如接触皮肤：使用大量水冲洗。如觉不适，呼叫解毒中心或就医。
P304 + P340如误吸入：将人转移到空气新鲜处，保持呼吸舒适体位。
P342 + P311如有呼吸系统病症：呼叫解毒中心或医生。
P362 + P364脱掉所有沾染的衣服，清洗后方可重新使用。
P391收集溢出物。
废弃处置
P501将内装物/容器送到批准的废物处理厂处理。
2.3 其它危害物 - 无
模块3. 成分/组成信息
3.1 物 质
: C4H8Cl3O4P
分子式
: 257.44 g/mol
分子量
组分浓度或浓度范围
Trichlorfon
化学文摘登记号(CAS52-68-6<= 100 %
No.)200-149-3
EC-编号015-021-00-0
索引编号
模块4. 急救措施
4.1 必要的急救措施描述
一般的建议
请教医生。 向到现场的医生出示此安全技术说明书。
吸入
如果吸入,请将患者移到新鲜空气处。 如呼吸停止，进行人工呼吸。 请教医生。
皮肤接触
用肥皂和大量的水冲洗。 请教医生。
眼睛接触
用大量水彻底冲洗至少15分钟并请教医生。
食入
切勿给失去知觉者喂食任何东西。 用水漱口。 请教医生。
4.2 主要症状和影响，急性和迟发效应
据我们所知，此化学，物理和毒性性质尚未经完整的研究。
4.3 及时的医疗处理和所需的特殊处理的说明和指示
无数据资料
模块5. 消防措施
5.1 灭火介质
灭火方法及灭火剂
用水雾，耐醇泡沫，干粉或二氧化碳灭火。
5.2 源于此物质或混合物的特别的危害
碳氧化物, 磷的氧化物, 氯化氢气体
5.3 给消防员的建议
如有必要，佩戴自给式呼吸器进行消防作业。
5.4 进一步信息
无数据资料
模块6. 泄露应急处理
6.1 作业人员防护措施、防护装备和应急处置程序
使用个人防护装备。 避免粉尘生成。 避免吸入蒸气、气雾或气体。 保证充分的通风。
将人员疏散到安全区域。 避免吸入粉尘。
6.2 环境保护措施
如能确保安全，可采取措施防止进一步的泄漏或溢出。 不要让产品进入下水道。 避免排放到周围环境中。
6.3 泄漏化学品的收容、清除方法及所使用的处置材料
收集和处置时不要产生粉尘。 扫掉和铲掉。 放入合适的封闭的容器中待处理。
6.4 参考其他部分
丢弃处理请参阅第13节。
模块7. 操作处置与储存
7.1 安全操作的注意事项
避免接触皮肤和眼睛。 避免形成粉尘和气溶胶。
在有粉尘生成的地方,提供合适的排风设备。
7.2 安全储存的条件,包括任何不兼容性
贮存在阴凉处。 使容器保持密闭，储存在干燥通风处。
7.3 特定用途
无数据资料
模块8. 接触控制和个体防护
8.1 控制参数
职业接触限值
组分化学文摘登值控制参数依据
记号(CAS
No.)
Trichlorfon52-68-6PC-0.5 mg/m3工作场所有害因素职业接触限值 -
TWA化学有害因素
PC-1 mg/m3工作场所有害因素职业接触限值 -
STEL化学有害因素
8.2 暴露控制
适当的技术控制
按照良好的工业卫生和安全规范进行操作。 休息前及工作结束时洗手。
个体防护装备
眼面防护
面罩與安全眼鏡请使用经官方标准如NIOSH (美国) 或 EN 166(欧盟) 检测与批准的设备防护眼部。
皮肤保护
戴手套取 手套在使用前必须受检查。
请使用合适的方法脱除手套(不要接触手套外部表面),避免任何皮肤部位接触此产品.
使用后请将被污染过的手套根据相关法律法规和有效的实验室规章程序谨慎处理. 请清洗并吹干双手
所选择的保护手套必须符合EU的89/686/EEC规定和从它衍生出来的EN 376标准。
身体保护
全套防化学试剂工作服, 防护设备的类型必须根据特定工作场所中的危险物的浓度和数量来选择。
呼吸系统防护
如须暴露于有害环境中,请使用P95型(美国)或P1型(欧盟 英国
143)防微粒呼吸器。如需更高级别防护,请使用OV/AG/P99型(美国)或ABEK-P2型 (欧盟 英国 143)
防毒罐。
呼吸器使用经过测试并通过政府标准如NIOSH（US）或CEN（EU）的呼吸器和零件。
模块9. 理化特性
9.1 基本的理化特性的信息
a) 外观与性状
形状: 固体
b) 气味
无数据资料
c) 气味阈值
无数据资料
d) pH值
无数据资料
e) 熔点/凝固点
无数据资料
f) 初沸点和沸程
无数据资料
g) 闪点
无数据资料
h) 蒸发速率
无数据资料
i) 易燃性(固体,气体)
无数据资料
j) 高的/低的燃烧性或爆炸性限度 无数据资料
k) 蒸气压
无数据资料
l) 蒸气密度
无数据资料
m) 密度/相对密度
1.730 g/cm3 在 20 °C
n) 水溶性
可溶
o) 正辛醇/水分配系数
log Pow: 0.51log Pow: 5
p) 自燃温度
无数据资料
q) 分解温度
无数据资料
r) 黏度
无数据资料
模块10. 稳定性和反应活性
10.1 反应性
无数据资料
10.2 稳定性
无数据资料
10.3 危险反应
无数据资料
10.4 应避免的条件
无数据资料
10.5 不相容的物质
强氧化剂
10.6 危险的分解产物
其它分解产物 - 无数据资料
模块11. 毒理学资料
11.1 毒理学影响的信息
急性毒性
LD50 经口 - 大鼠 - 882 mg/kg
LC50 吸入 - 大鼠 - 1,300 mg/m3
LD50 经皮 - 大鼠 - 2,000 mg/kg
皮肤腐蚀/刺激
无数据资料
严重眼睛损伤/眼刺激
眼睛 - 家兔 - 轻度的眼睛刺激
呼吸或皮肤过敏
无数据资料
吸入可引起过敏。
生殖细胞致突变性
体外基因毒性 - Ames试验 - 阳性
致癌性
致癌性 - 大鼠 - 皮肤
肿瘤发生：符合RTECS标准的可疑致癌试剂。 肝脏：肿瘤
致癌性 - 大鼠 - 肌肉内的
肿瘤发生：符合RTECS标准的致癌性。 肝脏：肿瘤 血：肿瘤。
致癌性 - 大鼠 - 经口
肿瘤发生：符合RTECS标准的致癌性。 肝脏：肿瘤 血：肿瘤。
IARC:
3 - 第3组：未被分类为对人类致癌 (Trichlorfon)
生殖毒性
特异性靶器官系统毒性（一次接触）
无数据资料
特异性靶器官系统毒性（反复接触）
无数据资料
吸入危害
无数据资料
潜在的健康影响
吸入吸入可能有害。 可能引起呼吸道刺激。
食入吞咽有害。
皮肤通过皮肤吸收有害。 可能引起皮肤刺激。
眼睛引起眼睛刺激。
接触后的征兆和症状
据我们所知，此化学，物理和毒性性质尚未经完整的研究。
附加说明
化学物质毒性作用登记: TA0700000
模块12. 生态学资料
12.1 生态毒性
对鱼类的毒性LC50 - Oncorhynchus mykiss (虹鳟) - 0.114 mg/l - 96.0 h
LC50 - Oncorhynchus mykiss (虹鳟) - 0.7 mg/l - 96.0 h
对水溞和其他水生无脊EC50 - Daphnia magna (水溞) - 0.00005 mg/l - 48 h
椎动物的毒性
12.2 持久性和降解性
12.3 潜在的生物累积性
生物富集或生物积累性Cyprinodon variegatus (红鲈) - 96 h -26.9 mg/l
生物富集因子 (BCF): 0.11
12.4 土壤中的迁移性
无数据资料
12.5 PBT和vPvB的结果评价
无数据资料
12.6 其他不良影响
对水生生物毒性极大。
模块13. 废弃处置
13.1 废物处理方法
产品
将剩余的和不可回收的溶液交给有许可证的公司处理。
与易燃溶剂相溶或者相混合，在备有燃烧后处理和洗刷作用的化学焚化炉中燃烧
受污染的容器和包装
按未用产品处置。
模块14. 运输信息
14.1 联合国编号
欧洲陆运危规: 3077国际海运危规: 3077国际空运危规: 3077
14.2 联合国运输名称
欧洲陆运危规: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S. (Trichlorfon)
国际海运危规: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S. (Trichlorfon)
国际空运危规: Environmentally hazardous substance, solid, n.o.s. (Trichlorfon)
14.3 运输危险类别
欧洲陆运危规: 9国际海运危规: 9国际空运危规: 9
14.4 包裹组
欧洲陆运危规: III国际海运危规: III国际空运危规: III
14.5 环境危险
欧洲陆运危规: 是国际海运危规国际空运危规: 是
海洋污染物（是/否）: 是
14.6 特殊防范措施
无数据资料
模块 15 - 法规信息
N/A
模块16 - 其他信息
N/A

海关数据

中国海关编码：2931900045

概述：

2931900045 敌百虫,氟硅菊酯,毒壤膦等〔包括苯硫膦,溴苯膦,苯腈膦,丁酯膦〕。监管条件:S(进出口农药登记证明)。增值税率:17.0%。退税率:9.0%。最低关税:6.5%。普通关税:30.0%

摘要/Summary：

2931900045 dimethyl (2,2,2-trichloro-1-hydroxyethyl)phosphonate。supervision conditions:s(import or export registration certificate for pesticides)。VAT:17.0%。tax rebate rate:9.0%。MFN tarrif:6.5%。general tariff:30.0%

分子结构与计算化学数据

分子结构数据

1、摩尔折射率：46.95

2、摩尔体积（cm³/mol）：163.5

3、等张比容(90.2K)：427.2

4、表面张力(dyne/cm)：46.6

5、极化率(10-24cm³)：18.61

计算化学数据

1.疏水参数计算参考值（XlogP）:无

2.氢键供体数量:1

3.氢键受体数量:4

4.可旋转化学键数量:3

5.互变异构体数量:无

6.拓扑分子极性表面积55.8

7.重原子数量:12

8.表面电荷:0

9.复杂度:183

10.同位素原子数量:0

11.确定原子立构中心数量:0

12.不确定原子立构中心数量:1

13.确定化学键立构中心数量:0

14.不确定化学键立构中心数量:0

15.共价键单元数量:1